Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Kerr

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Diabetes Care|May 20, 2011
Post hoc subgroup analysis of the HEART2D trial demonstrates lower cardiovascular risk in older patients targeting postprandial versus fasting/premeal glycemiaItamar Raz, Antonio Ceriello, Peter W Wilson, et al.
BMC Rheumatology|March 20, 2019
Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients' health-related quality of life and productivityLaura C Coates, Ana-Maria Orbai, Akimichi Morita, et al.
Lancet (London, England)|May 29, 2017
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trialPeter Nash, Bruce Kirkham, Masato Okada, et al.
Diabetes Care|February 28, 2009
Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trialItamar Raz, Peter W F Wilson, Krzysztof Strojek, et al.
The Journal of Antimicrobial Chemotherapy|January 22, 2017
Therapeutic drug monitoring and use of an adjusted body weight strategy for high-dose voriconazole therapyPatrick G Richards, Kimberlyn M Dang, Carol A Kauffman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 8, 2021
Withdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double-Blind Withdrawal StudyLaura C Coates, Sreekumar G Pillai, Hasan Tahir, et al.
Open Forum Infectious Diseases|March 4, 2015
Spinal and paraspinal fungal infections associated with contaminated methylprednisolone injectionsVarsha Moudgal, Bonita Singal, Carol A Kauffman, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Diabetes Care|May 20, 2011
Post hoc subgroup analysis of the HEART2D trial demonstrates lower cardiovascular risk in older patients targeting postprandial versus fasting/premeal glycemiaItamar Raz, Antonio Ceriello, Peter W Wilson, et al.
BMC Rheumatology|March 20, 2019
Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients' health-related quality of life and productivityLaura C Coates, Ana-Maria Orbai, Akimichi Morita, et al.
Lancet (London, England)|May 29, 2017
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trialPeter Nash, Bruce Kirkham, Masato Okada, et al.
Diabetes Care|February 28, 2009
Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trialItamar Raz, Peter W F Wilson, Krzysztof Strojek, et al.
The Journal of Antimicrobial Chemotherapy|January 22, 2017
Therapeutic drug monitoring and use of an adjusted body weight strategy for high-dose voriconazole therapyPatrick G Richards, Kimberlyn M Dang, Carol A Kauffman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 8, 2021
Withdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double-Blind Withdrawal StudyLaura C Coates, Sreekumar G Pillai, Hasan Tahir, et al.
Open Forum Infectious Diseases|March 4, 2015
Spinal and paraspinal fungal infections associated with contaminated methylprednisolone injectionsVarsha Moudgal, Bonita Singal, Carol A Kauffman, et al.
Pageof 3